Cartalax: doses reported in published research
Sources checked 2026-10-07 · 1 cited study (0 human, 0 animal, 1 cell culture)
Cartalax is the tripeptide Ala-Glu-Asp (AED). No PubMed record uses the name "Cartalax"; the only dose found is from a cell-culture study that tested AED by its sequence.
No human data. and no animal data: the only published amount found is from one cell-culture study.
Cell-culture studies (1)
Cell culture (in vitro) Human periodontal ligament stem cells in culture (AED tested alone and in peptide mixtures)
- Dose as reported
- 0.01 µg/mL
- Route
- Added to cell culture medium
- Frequency / duration
- Medium replaced every 3 days
Source wording: All the peptides were diluted in phosphate-buffered saline (PBS) at a concentration of 0.01 µg/mL and were added to cell medium and replaced every 3 days.
short peptides AED (Ala-Glu-Asp), KED, KE (Lys-Glu), and AEDG
Caputi S, Trubiani O, Sinjari B et al.. Effect of short peptides on neuronal differentiation of stem cells. Int J Immunopathol Pharmacol 2019. PubMed PMID 30791821 ↗ · full text PMC6376556 ↗
Half-life
No half-life value was found in the sources reviewed for this page.
About this page
- Every figure above is copied from the cited source; the source wording is shown with each entry. Where a source does not state something, the page says so.
- Only abstracts, open-access full texts, registry records and FDA labels were used, so details found only in a paywalled full text may be missing.
- This page does not convert doses between species or into other measures, and gives no preparation or handling information.
See also: Cartalax research profile · lab-tested lots (COA lookup) · all compounds in this section.